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Nucleostemin as a possible progenitor marker of corneal epithelial
cells
Motoko Kawashima, Tetsuya Kawakita, Satoru Yoshida, Shigeto Shimmura, Kazuo Tsubota
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan
Purpose: Nucleostemin, a nuclear protein involved in the regulation of cell cycle and proliferation, is a candidate marker
for various stem cells. We examined the expression of nucleostemin as a marker of differentiation and senescence in
corneal epithelial progenitor cells.
Methods: Nucleostemin expression in normal mouse corneal epithelium was examined by RT-PCR, as well as in cultured
mouse corneal epithelial cells by immunohistochemistry. Co-expression with the progenitor markers p63 and Bmi-1,
cytokeratin 14 and 19, the proliferating marker Ki67, differentiation markers cytokeratin 12 and involucrin, and with the
senescent marker SA-β-gal were examined by immunohistochemistry. Correlation of cellular size and nucleostemin
expression was also examined.
Results: Nucleostemin expression was detected in mouse corneal epithelium by RT-PCR. Immunohistochemistry revealed
that nucleostemin was expressed predominantly in basal and suprabasal cells of the whole cornea. The expression of
nucleostemin was not associated with the expression of Ki67, K14, and K19, but with the expression of Bmi-1 and
particularly with p63. Nucleostemin was not co-expressed with SA-β-gal in same cell.
Conclusions: Nucleostemin can be used as a progenitor marker analogous to p63.
Nucleostemin (guanine nucleotide binding protein-like 3,
Gnl3)  encodes  a  nucleolar  GTP-binding  protein  highly
enriched  in  stem  cells  and  cancer  cells  [1-5],  including
embryonic stem cells [1,2], neural stem cells [1,2,4], and
cancer  stem  cells  [1,5],  but  not  in  most  terminally
differentiated  cells  [6].  Nucleostemin  is  thought  to  be
involved in regulation of the cell cycle and proliferation [7].
When nucleostemin expression was knocked down in vitro by
siRNA, DNA synthesis failed to pass through the S phase in
Hela cells [7] and rat primary bone marrow stromal cells [3,
8].  When  cell  proliferation  was  stimulated  by  FGF2,
nucleostemin expression was increased in a dose-dependent
manner [3], suggesting nucleosteminn expression could be
promoted by specific microenvironment. However such an
increase of nucleostemin expression by RT-PCR could simply
be  the  result  of  the  proliferation  of  nucleostemin-positive
cells, and not the result of promoting nucleostemin expression
within each cell.
In  vivo,  the  embryogenesis  of  homozygous
nucleostemin-null mice was aborted before the blastula stage.
Although  the  growth  and  fertility  of  heterozygous
nucleostemin-null mice appeared normal, mouse embryonic
fibroblasts  (MEFs)  derived  from  these  mice  had  less
nucleostemin protein, a lower population growth rate, and
higher percentages of senescent cells than their wild-type
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littermates,  which  could  be  rescued  by  transgenic
overexpression of nucleostemin [9].
In  this  study,  we  investigated  the  expression  of
nucleostemin as a possible marker for corneal progenitor/stem
cells.  To  address  the  issue,  we  examined  the  in  vivo
localization  of  nucleostemin  in  the  mouse  cornea,  and
compared  expression  patterns  with  known  markers  for
progenitor  cells,  cell  proliferation  and  differentiation.  We
further  used  cultured  mouse  corneal  epithelial  cells  to
demonstrate the relationship of nucleostemin expression with
cellular senescence.
METHODS
Tissue preparation and cell culture: C57BL/6 mice (CLEA
Japan Inc, Tokyo, Japan), aged 8-10 weeks, were handled
according to the guidelines in the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research. Eye
globes were enucleated from the mice with forceps after death,
washed profusely in phosphate buffered saline (PBS). For
immunostaining, whole eyes were cryopreserved. For primary
culture,  mouse  corneal  epithelial  cells  were  isolated  and
cultured  by  explant  method  as  described  previously  [10].
Briefly, corneal buttons, including the limbus, were cut from
the mouse eye and extraneous tissue removed including the
iris and ciliary body. The button was cut in half and each
explant with epithelium side up was plated flat on a 6 well
plate, one piece per well. After approximately 5-10 min, to
allow  for  attachment  of  the  explant,  serum-free  low-Ca2+
medium (defined keratinocyte serum-free medium, KSFM;
Invitrogen,  Carlsbad,  CA)  containing  of  10  ng/ml  human
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1162recombinant EGF (Invitrogen), 100 ng/ml cholera toxin (LIST
Biological Laboratories Inc., Campbell, CA), antibiotics, and
growth supplement supplied by the manufacturer was added.
The cultures were incubated at 37 °C, under 95% humidity
and 5% CO2 with the medium changed every 3 to 4 days. After
approximately 10 days, the explant was carefully transferred
to a new dish and cultured as described above. Cells derived
from  passaged  explants  were  also  used  for  subcultures.
Epithelial  cells  were  subcultured  by  TrypLE  Express®
(Invitrogen)  at  1:3  splits  after  small  cells  reached
subconfluence, or if the colonies of small cells started to
stratify before reaching subconfluence. The procedure was
repeated  until  passage  4  (P4)  cultures.  The  cultures  were
incubated at 37 °C, under 95% humidity and 5% CO2 with the
medium changed every 3 to 4 days.
Reverse  transcription–polymerase  chain  reaction:  Total
RNA  was  extracted  from  mouse  corneal  epithelium  cells
cultured for 7 to 10 days using commercial RNA isolation kit
(RNeasy; Qiagen, Valencia, CA), and cDNA was synthesized
using a kit (RevaTra Ace; Toyobo, Osaka, Japan). The same
amount of cDNA was amplified by PCR (GeneAmp 9700;
Applied Bioscience, Inc, (ABI), Foster City, CA) for each
primer pairs as follows: Gnl3 (forward; Mm_Gnl3_1242_Fw
5'-AAG  CCC  AAA  TGT  GGA  AAG  TGC-3',  reverse;
Mm_Gnl3_1706_Rv 5'-TCA TCC TCT TGA CTC GCT CTA
TCC-3',  product  size,465  bp  ),  Gapdh  (forward;
Mm_Gapdh_565 Fw 5'-GAC CAC AGT CCA TGC CAT
CAC-3', reverse; Mm_Gapdh_1107 Rv 5'-TCC ACC ACC
CTG TTG CTG TAG-3', product size 453 bp). PCR products
were analyzed by agarose gel electrophoresis.
Figure 1. Nucleostemin expression in mouse cornea in vivo. A: The nucleostemin (Gnl3) band was detected in corneal epithelium by RT-PCR.
B, C, and D: Immunostaining of mouse corneal section revealed that nucleostemin was expressed in the basal and suprabasal layer of cornea.
Double immunostaining with Ki67 (B), Bmi-1(C), and p63 (D) revealed that p63 was the most similar expression pattern as nucleostemin in
vivo mouse cornea. In C and D, the bars indicate 50 μm.
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1163Immunostaining: Mouse corneal epithelial cells were cultured
in twenty-four well plates (104 cells/well) and fixed with 2%
paraformaldehyde (PFA, Wako, TX) for the immunostaining
of p63, Ki67, Bmi-1, involcrin, K12, K14, and nucleostemin.
Corneal  tissues  were  also  fixed  with  2%  PFA  for  the
immunostaining of p63, K12, K14, K19, and nucleostemin.
PFA-fixed cells were permeabilized with 0.1% Triton X-100
(Sigma-Aldrich, St. Louis, MO). After background staining
was blocked with 10% normal donkey serum, the cells and
tissues were treated with the following monoclonal primary
antibodies:  anti-p63  (4A4;  Calbiochem,  Darmstadt,
Germany),  anti-K12  (Transgenic  Inc.,  Kumamoto,  Japan),
anti-K14 (Abcam, Cambridge, UK), anit-K19 (Neomarker,
Fremont, CA), anti-involcrin (SY5; Abcam, Tokyo, Japan),
anti-Bmi-1  (1.T.21;  Abcam),  anti-Ki67  (TEC-3;  Dako,
Glostrup, Denmark) and anti-nucleostemin (R&D Systems,
Minneapolis, MN). The cells or tissues were then treated with
Cy3-  or  FITC-conjugated  secondary  antibodies  (Jackson
ImmunoResearch,  West  Grove,  PA).  The  nuclei  were
counterstained with 4', 6’-diamino-2-phenylindole (DAPI, 1
μg/ml; Dojindo Laboratories, Tokyo, Japan).
Analysis of nucleostemin expression: To compare the signal
intensity of nucleostemin expression between small and large
cells,  P2  cells  were  immunostained  against  nucleostemin.
Staining  was  scored  by  two  independent  observers  as  ++
(most intense), +, or - (least intense) depending on staining
intensity. A minimum of ten fields were examined for each
set of 3 wells. Cells were divided into two group according to
cell size determined by whether half the length of the major
and minor axis was greater or smaller than 100 μm.
Senescence-associated  β-gal  staining:  Mouse  corneal
epithelial cells were cultured in 4 well chamber slides (104
Figure 2. Expression pattern of nucleostemin with cytokeratin in mouse corneal epithelium in vivo. Immunostaining against nucleostemin
with cytokeratin 19 (K19), K14, and K12 was performed in mouse corneal epithelium was performed. A: K19 was expressed in basal limbal
epithelial layer, but nucleostemin was expressed in basal layer of cornea and linmbus. B: K14 expression was observed in suparabasal- and
basal layer as nucleostemin, but nucleostemin expression was deteced in more cells than K14. K12 was observed in whole corneal layers in
central and limbal location (C), and nucleostemin expression was similarly detected in central cornea and limbus. The bars indicate 20 (B) or 50
μm (A and C).
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1164cells/well),  and  fixed  after  7  days  to  detect  senescence-
associated  β-gal  staining  (SA-β-gal)  with  a  Senescence
Detection Kit (BioVision, Mountain View, CA). For double
staining, nucleostemin antibody binding was visualized by the
avidin-biotin-immuno  peroxidase  complex  method  using
the Vectastain Elite ABC Goat IgG Kit (Vector Laboratories,
Inc.,  Burlingame,  CA)  according  to  the  manufacturer’s
instructions.
RESULTS
Nucleostemin  expression  in  mouse  cornea  in  vivo:  In  the
mouse  cornea,  a  single  nucleostemin  band  was  clearly
detected by RT-PCR (Figure 1A). In mouse corneal radial
sections,  immunostaining  revealed  that  nucleostemin  was
expressed in the basal and suprabasal layers of the corneal
epithelia,  including  the  limbus  (Figure  1B-D).  To  further
characterize nucleostemin-positive cells, the expression of the
proliferation marker Ki67, the progenitor markers p63 and
Bmi-1, as well as cytokeratin 12 (K12), K14, and K19 were
examined. Double immunostaining with Ki67, Bmi-1, and
p63 revealed that p63 had the most similar expression pattern
as  nucleostemin  in  vivo  (Figure  1B-D).  Expression  of
nucleostemin was compared with K19, K14, and K12 in the
mouse corneal epithelium. K19 was expressed in basal layer
of limbal epithelium, however, nucleostemin was expressed
in the basal layer of both cornea and limbus (Figure 2A).
Nucleostemin  overlapped  with  K14  expression  in  the
suparabasal and basal epithelial cells (Figure 2B). K12 was
observed in all layers of the central cornea and limbus (Figure
2C).
Figure 3. Expression of nucleostemin in primary mouse corneal epithelial culture. Immunostaining against nucleostemin with progenitor (p63),
proliferative (Ki67), basal cell (K14), and differentiation marker (involucrin) was performed in primary mouse corneal epithelial culture. The
result showed that p63 was mostly overlapped with nucleostemin expression. Ki67 was only expressed in small population of nucleostemin
positive cells with small nucleus. K14 was expressed in most of the attached cells accompanied with nucleostemin expression, but some cell
showed K14 positive but nucleostemin negative. (indicated by the asteriak) Involucrin was not expressed in nuclestemin positive cells
completely. The bars indicate 100μm.
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1165Expression  of  nucleostemin  in  primary  mouse  corneal
epithelial cultured cells: Primary culture of mouse corneal
epithelial cells was used for further characterization in vitro.
Immunostaining  was  done  against  nucleostemin  and
compared with p63, Ki67, K14, and with the differentiation
marker, involucrin. (Figure 3A-D). The result showed that p63
overlapped with nucleostemin, similar to what was observed
in the mouse corneal epithelium. The proliferation marker
Ki67  was  only  expressed  in  a  small  population  of
nucleostemin-positive cells with small nuclei. Most of the
attached  cells  expressed  K14  and  nucleostemin,  however,
some  cell  were  K14-positive  but  nucleostemin-negative.
Involucrin was exclusively expressed in nuclestemin-negative
cells (Figure 3D, indicated by the asterisk).
Nucleostemin expression and cellular senescence in primary
mouse corneal epithelial culture: The expression of Bmi1
decreased with cellular senescence, and was therefore used as
a negative marker of cellular senescence. Although nuclear
expression of Bmi1 mostly overlapped with nucleostemin in
small  cells,  some  of  Bmi1-positive  large  cells  were
nucleostemin-negative (Figure 4A). SA-ß-gal staining was
observed in cells with relatively large cytoplasm and nuclei,
while nucleostemin-positive cells and/or small compact cells
were completely negative for SA-β- gal staining (Figure 4B).
Nucleostemin expression and cell size in primary culture: Cell
size varied during early passages (P1-P3) of primary mouse
corneal epithelial culture, and therefore these cells were used
for  analyzing  the  correlation  between  cell  size  and
Figure 4. Nucleostemin expression and cellular senescence in primary mouse corneal epithelial culture. Bmi1 expression was mostly
overlapped with nucleostemin expression (A) as p63 in different location. It was noted that some large cells were also Bmi1-positive and
nucleostemin-negative. A: Senescent cells display the increase of cell size, and the expression of senescence-associated Beta-galactosidase
(SA-ß-gal) activity. Nucleostemin-positive cells were not stained by SA-ß-gal. B: The SA-ß-gal is not found in small compact cells (B). Bars
indicate 100μm.
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1166nucleostemin expression (Figure 5A). Immunostaining in P2
showed  that  small  cells  were  strongly  positive  for
nucleostemin, but large cells were negative. Signal intensity
of  nucleostemin  was  significantly  higher  in  small  cells
compared to large cells (Figure 5A). All cells with a cell size
of smaller than 100 μm expressed nucleostemin, while cells
lager  than  100  μm  showed  little  or  no  expression  of
nucleostemin (Figure 5B,C,D).
DISCUSSION
The  expression  of  nucleostemin  has  been  reported  in
proliferating cells in various tissues including bone marrow
stromal cells [1-3], malignancies [1,5,11,12], and skin [13].
In skin, nuclostemin was expressed more in keratinocyte on
feeder  cells  than  those  without  feeder  cells  [13],  which
supported  the  fact  that  nucleostemin  may  be  used  as  a
progenitor  marker  for  stratified  epithelial  cells.  However,
corneal  epithelial  cells  are  different  from  epidermal
keratinocytes due to its avascularity, and a non-keratinized,
transparent morphology. At present, no data concerning its
expression in normal corneal epithelia are available. In this
study, nucleostemin expression was observed in vivo and in
vitro  mouse  corneal  epithelial  cells.  Although  the
immunostaining pattern in corneal epithelium was similar to
epidermal tissue, no staining was observed in corneal stroma,
unlike in dermal tissue. This discrepancy could be explained
by the fact that cell mitosis is more frequent in epidermis than
corneal stroma.
Comparing  nucleostemin  expression  with  various
markers  showed  that  p63  (4A4)  showed  the  most  similar
staining pattern in the mouse cornea both in vivo and in vitro.
The expression of p63 is often used as a progenitor marker for
keratinocytes and cornea [14,15]. The localization of p63 by
immunostaining  was  observed  as  uniform  staining  of  the
nucleus,  which  is  sometimes  confused  with  non-specific
background  staining.  However  the  expression  of
nucleostemin  was  observed  as  strong  signals  from  the
nucleoli, which is much more specific compared to p63, and
therefore, may be superior as a progenitor marker. Bmi1,
recognized as a progenitor marker for cornea, revealed similar
expression  with  nucleostemin  in  vitro.  However,  in  vivo,
nucleostemin expression was broader than Bmi1, which was
reported to decrease during aging and cellular senescence
[16,17].We used subcultured cells for this experiments, which
could explain the difference between in vivo and in vitro.
Nucleostemin  expression  is  an  indicator  of  the
proliferative  capacity  of  cells.  On  the  other  hand,
nucleostemin  expression  is  not  directly  connected  to
proliferation. Since nucleostemin is widely expressed in cells
of normal and malignant renal tissue [11], it is reasonable to
presume  that  nucleostemin  has  tasks  other  than  simply
regulating proliferation. In primary rat cortical stem cells,
nucleostemin expression appears to control proliferation and
onset of apoptosis. The lack of nucleostemin was connected
with  the  lack  of  cell  proliferative  activity,  but  the
overexpression  of  nucleostemin  was  connected  with  the
induction of apoptosis [1]. In this study, all Ki67-positive cells
were  strongly  positive  for  nucleostemin,  and  many  Ki67-
negative cells also maintained nucleostemin expression in the
corneal basal and suprabasal epithelial layers. The strength of
nucleostemin expression in the cornea may not correlate with
the induction of apoptosis in vivo.
K14 is expressed in basal epithelial cells with the capacity
for stratification [18,19], and nucleostemin expression was
Figure 5. Nucleostemin expression and
cell size in primary culture. Cell size was
different  in  early  passage  (P1-P3)  of
primary  mouse  corneal  culture,
therefore  those  cells  were  used  for
analyzing correlation between cell size
and  nucleostemin  expression.  A:
Immunostaining  in  P2  showed  that
small  cells  were  strongly  positive  in
nucleostemin,  but  negative  in  large
cells. All of the cells with the cell size of
smaller  than  100  μm  expressed
nucleostemin (B and C), however cells
with  the  size  of  larger  than  100  μm
showed  less  or  no  expression  of
nucleostemin (B and D).
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1167similar to K14 in vivo. In vitro, K14 was expressed in most
attached cells, while nucleostemin was expressed in a subset
of K14-positive cells, indicating that K14 expression may not
be related to the proliferating capacity of cells.
By  analyzing  the  correlation  between  cell  size  and
nucleostemin  expression,  the  decrease  or  absence  of
nucleostemin  was  observed  in  large  flatten  cells.
Immunostaining  showed  that  small  cells  were  strongly
positive  in  nucleostemin,  but  negative  in  large  cells.
Furthermore,  SA-β-gal  positive  cells  did  not  express
nucleostemin, which shows that nucleostemin is not expressed
in senescent cells.
In conclusion, nucleostemin is available as a marker for
p63-positive progenitor and non-senescent cells of the corneal
epithelium.  The  unique  staining  pattern  of  nucleostemin
within the nucleoli may have an advantage over p63, in which
background staining and isotype specificity is often debated.
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